Filing Details
- Accession Number:
- 0001325812-15-000019
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-03 18:48:21
- Reporting Period:
- 2015-02-27
- Filing Date:
- 2015-03-03
- Accepted Time:
- 2015-03-03 18:48:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
873303 | Sarepta Therapeutics Inc. | SRPT | Pharmaceutical Preparations (2834) | 930797222 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1522780 | Md M. Edward Kaye | 215 First Street, Suite 7 Cambridge MA 02142 | Svp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-27 | 800 | $11.82 | 1,311 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Acquisiton | 2015-02-27 | 9,200 | $0.00 | 9,200 | $13.90 |
Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2015-02-27 | 153,800 | $0.00 | 153,800 | $13.90 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,200 | 2025-02-27 | No | 4 | A | Direct | |
153,800 | 2025-02-27 | No | 4 | A | Direct |
Footnotes
- Includes shares acquired under the Sarepta Therapeutics, Inc. 2013 Employee Stock Purchase Plan; 511 shares were acquired on August 29, 2014 at a price of $19.4905 and 800 shares were acquired on February 27, 2015.
- 25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.